1 In vivo microdialysis has been used to investigate the concentration of various amino acids and lactate in the extracellular fluid of the rat cortex following focal ischaemia, the probe being placed in the core of the infarct area. 2 An ischaemic infarct was produced in the cortex by use of a photochemical dye (Rose Bengal) and light irradiation. There was a marked increase in lactate concentration (300%) over the next 4 h. Substantial increases were also seen in the concentration of the excitatory (glutamate and aspartate), inhibitory (GABA and taurine) and other amino acids (serine, alanine, asparagine). 3 Administration of chlormethiazole (200 mg kg-', i.p.) 5 min after the onset of ischaemia reduced the ischaemia-induced neurodegeneration by approximately 30%, measured histologically 24 h later. 4 Chlormethiazole (200mg kg-', i.p.) administration also reduced the rise in the concentration of lactate and all the amino acids by between 30-60% during the first 4 h after the onset of ischaemia. 5 Analysis of the time course of the amino acid changes suggested that chlormethiazole is not neuroprotective because of the inhibition of excitatory amino acid release but rather that the attenuated rise in the concentration of all the amino acids is reflective of neuroprotection and therefore decreased cell death. 6 This conclusion was supported by the observation that the enhanced efflux of glutamate from slices of cerebral cortex which had been induced by incubation of the slices in an hypoxic medium was unaltered by the presence of a high concentration of chlormethiazole (1 mM) in the medium. 7 Overall the data strengthen the evidence for the neuroprotective effect of chlormethiazole in this model of focal ischaemia.
Introduction
Watson and colleagues (1985) have developed a relatively non-invasive method of producing an ischaemic infarct in the cortex by means of a photochemically induced thrombosis of cerebral arteries. An intravenous injection of the photosensitive dye, Rose Bengal, is given and a green light used to penetrate the skull of anaesthetized rats and illuminate subdural blood vessels. A photochemical reaction occurs with subsequent damage to the endothelial lining of blood vessels, platelet aggregation and thrombosis (Dietrich et al., 1987a,b; Grome et al., 1988; De Ryck et al., 1989; Laursen et al., 1991) . In the irradiated area of the cortex there is vascular stasis and ischaemic cell death (Watson et al., 1985; Snape et al., 1993; Baldwin et al., 1993b,c) .
Recently we reported that chlormethiazole, a drug already shown to be an effective neuroprotective agent in the gerbil model of transient global ischaemia (Cross et al., 1991; Baldwin et al., 1993a) reduced the size of the infarction in the photochemical model of focal ischaemia (Snape et al., 1993) . Dizocilpine, the N-methyl-D-aspartate antagonist, despite being neuroprotective in the gerbil model (Gill et al., 1987; Cross et al., 1991) was without protective effect in the photochemical model as was the AMPA antagonist NBQX [2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo (F) quinoxaline] (Baldwin et al., 1993c) . As both dizocilpine and NBQX are protective in other models of focal ischaemia (Gill et al., 1988; Park et al., 1988; Sheardown et al., 1990) this raises questions as to the involvement of glutamate in the mechanisms involved in cell death in the photochemical model.
The current study was undertaken therefore to investigate Author for correspondence. by use of in vivo microdialysis, the extracellular concentrations (and therefore presumably efflux) of various transmitter and non-transmitter amino acids and also lactate following a photochemically induced ischaemic episode and the effect of chlormethiazole on these concentrations. In this way it was hoped that knowledge would be gained both of the changes that follow photochemically induced ischaemia and also the mechanisms involved in the neuroprotective action of chlormethiazole.
Since a previous study (Baldwin et al., 1993c) found that the extracellular concentrations of amino acids and lactate did not change in non-ischaemic animals in the course of the experiment, it was considered reasonable to perform the study comparing only drug and non-drug treated ischaemic rats.
Methods

Animals
Male Lister hooded rats (Olac, U.K.) weighing 280-360 g at the time of surgery were used. Rats were housed in groups of 5 in a room with a 12 h light:12 h dark cycle (lights on at 07 h 00 min) and given food and water ad libitum.
Microdialysis AB, Sweden) was implanted horizontally via a guide cannule (CMAll, CMA Microdialysis AB) into the right cortex: -2.3 mm posterior and -2.0 mm ventral to the skull surface at bregma and the tip of the probe was located at ± 0.0 mm from the midline. A 6 mm diameter plastic ring was placed directly over the right cortex, behind bregma and tangential to the bregmoidal and midline skull sutures. The probe and plastic ring were secured to the skull with 2 screws and dental acrylic, leaving the skull inside the ring, free of acrylic. Rats were given 2 ml of 4% glucose in saline (s.c.) as a nutrient and placed in individual perspex cages (30 x 30 x 25 cm) to recover for 20 h.
Induction of ischaemia
Rats were anaesthetized with halothane (1.5-5.0%) in an oxygen/nitrous oxide mixture (1:2). Rose bengal (7.5 mg ml-') in saline was then injected slowly into the right jugular vein at a dose of 20 mg kg-' (Ca. 0.5-0.8 ml injected over 20 s). Immediately after the injection a fibre optic was positioned directly over the centre of the plastic ring above the skull (distance from fibre to skull <2.0 mm). This area of skull was irradiated for 7 min with light from a 150 W halogen source that had been passed through a green filter (Olympus Highlight 3000, Olympus, U.K.).
Five minutes after induction of ischaemia rats received an injection of either chlormethiazole (200 mg kg-', i.p.) or NaCI, 0.9% w/v (saline). Since the chlormethiazole-treated animals were sedated, they were placed on a heating mat under a blanket for the experiment. Saline-treated animals were replaced in the perspex boxes. The rectal temperature of both groups of animals was monitored and maintained at 37°C throughout the remainder of the experiment. Baldwin et al. (1993c) . Amino acid concentrations were measured by high performance liquid chromatography (h.p.l.c.) with fluorometric detection following precolumn derivatisation with o-pththalaldehyde as described by Lindroth et al. (1985) and briefly detailed by Baldwin et al. (1993c 
Collection of dialysate samples
Results
Effect of chlormethiazole on the infarct size following the ischaemic episode
The size of the cortical damage 24 h after the induction of ischaemia was measured in a series of sections taken through the irradiated area of cortex. The area of damage was reduced by approximately 30% in animals given chlormethiazole (200 mg kg-', i.p.) 5 min after the ischaemic episode ( Figure 1 ).
Effect of ischaemia on dialysate lactate concentrations
The concentration of lactate in the dialysate rose rapidly following the light exposure and onset of the ischaemic episode with a final concentration 4 h after the onset of ischaemia being around 300% higher than baseline ( Figure   2 ). Administration of chlormethiazole (200 mg kg-1, i.p.)
5 min after the onset of ischaemia attenuated this change although there was no difference in the first 30 min sample following the start of the ischaemic episode (Figure 2 ).
Effect of chlormethiazole on glutamate, aspartate, GABA and taurine concentrations in the dialysate
The glutamate concentration in the dialysate rose nearly 30 fold within 2 h of the start of ischaemia and this increase was decreased by approximately 40% in the chlormethiazoletreated rats (Figure 3a) . The ischaemia-induced rise in aspartate concentration was much smaller, but was also decreased by nearly 40% in chlormethiazole-injected rats (Figure 3b ). The concentration of GABA and taurine in the dialysate also rose significantly following the start of the ischaemic episode and these increases were attenuated by administration of chlormethiazole (Figures 3c and d) . The peak concentration of all 4 compounds was observed to occur approximately 2 h after the onset of ischaemia (Figure 3 ).
Effect of chlormethiazole on serine, alanine and asparagine concentrations in the dialysate
The concentrations of serine, alanine and asparagine amino acids increased in the dialysate following the onset of ischaemia with the concentration appearing to increase throughout the 4 h collection period (Figure 4) . Chlormethiazole-treated animals had a significantly smaller increase in the concentration of these amino acids in the dialysate in each case (Figure 4 ).
Effect of hypoxia and chlormethiazole on glutamate release from cortical slices Incubation of cortical slices in an oxygenated buffer resulted in a steady and modest release of glutamate into the medium ( Figure 5 ). When the slices were transferred to an hypoxic medium there was a marked increase in glutamate release, which was not affected by the presence of a high concentration (I mM) of chlormethiazole in the buffer ( Figure 5 ). Time (min) Figure 5 The effect of hypoxia on glutamate release from cortical slices. Slices of cortex were incubated in oxygenated buffer. After 6 min one group was continued in oxygenated buffer (0) 
Discussion
The finding of Snape et al. (1993) that chlormethiazole is neuroprotective in the photochemical model of ischaemic cell death was confirmed in the current investigation (Figure 1 ), thereby allowing confidence in the data obtained when the drug was used to investigate changes in the extracellular neurotransmitter amino acid concentrations which occur following ischaemia.
Previous data from this laboratory (Snape et al.,1993) have indicated that neuronal damage occurs very rapidly after the onset of ischaemia in the photochemical model of stroke, the damage observed at 4h being approximately 75% of the total damage present at 24 h, when damage is near maximal. This degree of damage is almost identical to that reported by Grome et al. (1988) . It therefore seems reasonable to suppose that the major biochemical changes which lead to the observed pathology are also occurring in the first 4 h. We previously demonstrated by use of in vivo microdialysis that there was a marked increase in the extracellular concentration of lactate following the induction of focal ischaemia using the photochemical model (Baldwin et al., 1993c ). This increase presumably indicated an increase in anaerobic metabolism and was consistent with findings in other ischaemia models (Kuhr & Korf, 1988) . We also found a clear increase in the efflux of the excitatory amino acid, glutamate (Baldwin et al., 1993c) , in agreement with the findings of others using different models of focal and global ischaemia (Benveniste et al., 1984; Globus et al., 1988; Butcher et al., 1990) . The current study has confirmed these observations and also found a marked increase in the excitatory amino acid, aspartate. All these data could therefore be used to suggest a key role for the excitatory amino acids in the development of the neurodegenerative changes which follow an ischaemic episode in the model, as has been proposed in others (Rothman & Olney, 1986; Choi et al., 1988; Meldrum, 1990) . The efflux of the inhibitory amino acid, GABA, was also found to increase at the same time (Baldwin et al., 1993c; this paper) as did the concentration of taurine, in agreement with studies in other ischaemic models (Benveniste et al., 1984; Butcher et al., 1990; Lekieffre et al., 1992) . It remains uncertain as to whether taurine is an inhibitory neurotransmitter.
However, there is certainly evidence for an inhibitory neuromodulatory role in the brain, possibly through an action at GABA receptors (see Oja & Kontro, 1990 ) and taurine has also been shown to assist in the recovery of neuronal function following hypoxia (Schurr et al., 1987) . There is also evidence that taurine is an important factor in cerebral osmoregulation (Kimelberg et al., 1990; Lehmann, 1990; Puka et al., 1991) . It could be postulated therefore that the release of taurine may be indirectly linked to mechanisms involved in limiting the development of the infarct, particularly as the infarct in this model is associated with a significant degree of oedema (Dietrich et al.,1987a; Laursen et al., 1991; Snape et al., 1993; Green & Cross, unpublished observations).
Chlormethiazole administration decreased the efflux of the excitatory amino acids in the infarct region, which would provide an attractive explanation for its neuroprotective action. However, it was also observed to decrease the efflux of the inhibitory amino acids, GABA and taurine. Furthermore the efflux of the amino acids not thought to have a neurotransmitter role in the brain (serine, alanine and asparagine) was decreased by a similar amount.
Since the dialysis probe was placed in the centre of the infarct region, directly under the illumination source, the changes in dialysate concentration reflect biochemical changes in the core of the infarct. This is important as chlormethiazole decreases the spread of damage (Snape et al., 1993; this paper) . We therefore have confidence that the neurochemical changes discussed above reflect neurochemical differences in the infarct region, not the fact that less tissue has been damaged in the region of the probe.
Following occlusion of the middle cerebral artery in rats, the rise in extracellular glutamate and aspartate peaked within the first hour post-ischaemia (Butcher et al.,1990) . After transient forebrain ischaemia, the extracellular concentrations of these amino acids rose even more rapidly (Benveniste et al., 1984) . In both models, extracellular levels of 'metabolic' amino acids (such as alanine and serine) increased relatively slowly and reached peak concentrations which were considerably lower than those of the neuroactive amino acids. In the present study the extracellular concentrations of neuroactive amino acids also rose to a greater extent than the metabolic amino acids; however, peak concentrations were not reached until at least 2 h after the onset of ischaemia.
What seems probable therefore is that the rise in the extracellular concentrations of all amino acids reflects the breakdown of damaged cells in the ischaemic area. The attenuation of this rise in the chlormethiazole-treated rats therefore relates to the neuroprotective effect of the drug, and is a reflection of fewer cells being damaged, rather than an inhibition of the ischaemia-induced release of glutamate and aspartate. Consistent with this contention was the observation that chlormethiazole, even at a high (1 mM) concentration, did not inhibit the hypoxia-induced release of glutamate in vitro.
Further support for these proposals comes from the fact that chlormethiazole administration afforded around 30% protection measured histologically and also decreased the efflux of amino acids into the extracellular space in the infarct area by approximately the same amount.
It should also be noted that the increase in extracellular lactate concentrations was diminished in the chlormethiazole-treated rats. However, there was no difference between control and chlormethiazole-treated rats in the lactate concentration in the dialysate collected over the first 30 min following the ischaemic episode. This suggests that chlormethiazole did not affect this immediate effect of ischaemia.
In this model, damage occurs rapidly (Grome et al., 1988) with Snape et al. (1993) observing that approximately 50% of the area of oedema and extravasation measured at 24 h was apparent 30 min after the infarct, a time when chlormethiazole had no effect on lactate concentrations.
Again it is likely that the difference in extracellular lactate after this time relates to neuroprotection. However, what cannot be ruled out at present is that a difference was not observed in lactate concentration between control and experimental groups in the first 30 min because chlormethiazole was either altering blood flow or routes of energy metabolism.
As stated earlier glutamate has often been claimed to play a key role in the pathological processes associated with neurodegeneration following an ischaemic episode. We have previously questioned its involvement in the photochemical model, based on our finding that dizocilpine and NBQX were not neuroprotective (Baldwin et al., 1993a) . The current study does not suggest that this opinion is unreasonable. Chlormethiazole did decrease the rise in extracellular glutamate which followed the ischaemic insult. However, it failed to have any effect on the release of this neurotransmitter from brain slices exposed to an hypoxic insult. We are therefore forced to conclude that the chlormethiazole-induced effect on glutamate in vivo is a reflection of its neuroprotective action which prevents cell death and concomitant glutamate release rather than an inhibition of glutamate release thereby affording neuroprotection. In this model of ischaemia therefore increased extracellular glutamate concentrations appear to be a consequence of neurodegeneration rather than the cause.
In conclusion, the in vivo microdialysis data described in this study have provided neurochemical data which support the histological evidence for the neuroprotective action of chlormethiazole in the photochemical model (Snape et al., 1993; this paper) . Although the results do not give any plausible explanation for the mechanism(s) by which chlormethiazole produces its protective effect, they do indicate that a specific action on excitatory amino acid release is unlikely.
